EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents
EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents
复制标题
DOI：
10.1016/j.cmi.2016.01.017
复制
发表时间：
2016-06-01
影响因子：
14.2
通讯作者：
Howard, S. J.
中科院分区：
文献类型：
--
作者：
Arendrup, M. C.;Meletiadis, J.;Howard, S. J.
ESCMID欧洲抗真菌药敏试验委员会（EUCAST）抗真菌药敏试验小组委员会（AFST）确定了isavuconazole和Aspergillus以及itraconazole和Candida spp的断点，发布了一份总结现有和新的质量控制菌株最低抑菌浓度范围的新文件，并修订了酵母和霉菌药敏试验方法文件。本技术说明基于EUCAST异戊康唑和伊曲康唑基本原理文档、EUCAST推荐的抗真菌药敏试验常规和扩展内部质量控制1.0版本，以及E. Def 7.3、E. Def 9.2和E. Def 9.3方法文档（http://www.eucast.org）。(C) 2016年欧洲临床微生物学与传染病学会。Elsevier Ltd.出版。版权所有。
The Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) has determined breakpoints for isavuconazole and Aspergillus and for itraconazole and Candida spp., released a new document summarizing existing and new minimum inhibitory concentration ranges for quality control strains and revised the method documents for yeast and mould susceptibility testing. This technical note is based on the EUCAST isavuconazole and itraconazole rationale documents, version 1.0 of the routine and extended internal quality control for antifungal susceptibility testing as recommended by EUCAST, and the E. Def 7.3, E. Def 9.2 and E. Def 9.3 method documents (http://www.eucast.org). (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.